Latest Share Chat

Oxford Biodyn Share News (OBD)

Oxford Biodyn Information

Buy OBD Shares
Add OBD to Watchlist
Add OBD to Alert

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 8.10

Bid: 8.10

Ask: 8.48

Change: -0.10 (-1.22%)

Spread: 0.38 (4.691%)

Open: 8.00

High: 8.50

Low: 8.00

Prev. Close: 8.20

Last checked at -

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

Fri, 17th Dec 2021 20:34

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Says its EpiSwitch Covid-19 severity test is available in the US and that it has seen increased interest following the resurgence of the Delta and Omicron variants. Says EpiSwitch can identify those with the greatest risk of experiencing critical, life-threatening disease because of a SARS-Cov-2 viral infection. Oxford BioDynamics expects to launch blood-based predictive tests in early 2022.

Current stock price: 34.00 pence

Year-to-date change: down 59%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

More News

24 Nov 2021 16:05

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning

22 Nov 2021 16:54

DIRECTOR DEALINGS: Croda general counsel sells GBP200,000 in shares

18 Nov 2021 16:20

IN BRIEF: Oxford BioDynamics director Diggle raises stake to 15%

25 Oct 2021 17:53

TRADING UPDATES: Ridgecrest ends Blue Air deal; Vast's Baita Plai hit

31 Aug 2021 21:35

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

31 Aug 2021 12:48

Oxford BioDynamics awarded $0.91m US PACT grant

(Sharecast News) - Oxford BioDynamics has been awarded an FNIH Partnership for Accelerating Cancer Therapies (PACT) grant, it announced on Tuesday, to use its 'EpiSwitch' diagnostic platform for the accurate prediction of a patient's response to immune checkpoint inhibitors (ICIs) from a routine blood sample.

15 Jun 2021 14:42

Latest Share Chat

Oxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning

DIRECTOR DEALINGS: Croda general counsel sells GBP200,000 in shares

IN BRIEF: Oxford BioDynamics director Diggle raises stake to 15%

TRADING UPDATES: Ridgecrest ends Blue Air deal; Vast's Baita Plai hit

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

Oxford BioDynamics awarded $0.91m US PACT grant

TRADING UPDATES: GB Group rebuilds dividend; IPF ups 2021 profit view

UK earnings, trading statements calendar - next 7 days

Oxford BioDynamics "significantly" expands UK facilities with new lab

IN BRIEF: Oxford BioDynamics inks EpiSwitch kit deal with Agilent

Oxford Biodynamics inks agreement with Agilent Technologies for EpiSwitch kit

AIM WINNERS & LOSERS: Time Out ditches Waterloo market, plans raise

IN BRIEF: Oxford BioDynamics launches Covid-19 severity test in US

UK shareholder meetings calendar - next 7 days

Latest Share Chat

Oxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Oxford BioDynamics Covid severity tests available in US

Login to your account

Quickpicks are a member only feature

Login to your account